Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Galactofuranose metabolism is valued as an important target for the development of new antituberculosis drugs. UDP-galactopyranose mutase, a central enzyme in galactofuranose biosynthesis, is essential for the growth and viability of mycobacteria. This enzyme catalyzes the conversion of UDP-galactopyranose into UDP-galactofuranose, the donor used by various galacto-furanosyltransferases. While D-galactofuranose residues are often found in important surface glycoconjugates of pathogenic bacteria, fungi and protozoan parasites, they are absent in the mammalian host, and thus their biosynthesis is an attractive target for the development of novel therapeutic strategies. In contrast to mycobacteria, the importance of galactofuranose for eukaryotic pathogens has not been ascertained because the enzymes involved in galactofuranose metabolism are unknown. Here, we report the identification and characterization of the first eukaryotic UDP-galactopyranose mutases. The genes encoding the enzymes were cloned from two different human pathogens: the parasite Leishmania major and the opportunistic fungus Aspergillus fumigatus. The newly identified eukaryotic enzymes exhibit 51% sequence identity, but are less than 20% identical to the prokaryotic counterparts. The sequence identity between pro- and eukaryotic enzymes is concentrated at amino acid residues that are involved in substrate and cofactor binding. Therefore, an inhibitor of UDP-galactopyranose mutase might be effective against a wide range of pathogenic organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Latgé, J. P., Kobayashi, H., Debeaupuis, J. P., Diaquin, M., Sarfati, J., Wieruszeski, J. M., Parra, E., Bouchara, J. P., & Fournet, B. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5424-5433.1994 · Cited by 319
Galactofuranose metabolism: a potential target for antimicrobial chemotherapy
Pedersen, L. L., & Turco, S. J. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180300021 · Cited by 169 · cited 1×
“Importantly, Galf is not present in humans, and therefore the molecules involved in its synthesis represent attractive targets for the development of new antimicrobial drugs (Pedersen and Turco, 2003).”
Background
Cited by
Galactofuranose in eukaryotes: aspects of biosynthesis and functional impact
Tefsen, B., Ram, A. F., van Die, I., & Routier, F. H. (2012) · Glycobiology · doi:10.1093/glycob/cwr144 · Cited by 149
Self-citationGalactofuranose attenuates cellular adhesion of Aspergillus fumigatus
Lamarre, C., Beau, R., Balloy, V., Fontaine, T., Hoi, J. W. S., Guadagnini, S., Berkova, N., Chignard, M., Beauvais, A., & Latgé, J.-P. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01352.x · Cited by 98
“In A. fumigatus, the UGM gene (Afu3g12690) was identified through its identity to the Leishmania orthologue (Bakker et al., 2005).”
BackgroundInfluentialKomachi, Y., Hatakeyama, S., Motomatsu, H., Futagami, T., Kizjakina, K., Sobrado, P., Ekino, K., Takegawa, K., Goto, M., Nomura, Y., et al. (2013) · Molecular Microbiology · doi:10.1111/mmi.12416 · Cited by 73
“…(UgeA) is responsible for the conversion of UDP-glucose to UDP-galactopyranose (Galp) (El-Ganiny et al., 2010), which is then converted to UDP-Galf by UDP-Galp mutase (UgmA/GlfA) in the cytosol (Bakker et al., 2005; Damveld et al., 2008; El-Ganiny et al., 2008; Schmalhorst et al., 2008).”
Background
Metadata
- Authors
- Bakker, H., Kleczka, B., Gerardy-Schahn, R., & Routier, F. H.
- Venue
- Biological Chemistry
- Publisher
- Walter de Gruyter GmbH
- Published
- 2005-01-01
- Volume
- 386
- Issue
- 7
- Pages
- 657-61
- ISSN
- 1431-6730 (ISSN-L)
- 1437-4315
- OpenAlex
- W2046618728
- Cited by
- 70
- References
- 2
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.